Primary approach via laparotomy | Primary laparoscopic approach | P | |||
---|---|---|---|---|---|
(n = 61) | (58.1%) | (n = 44) | (41.9%) | ||
Age, median (years) | 59 | 47 | 0.006 a | ||
range | 13-85 | 16-86 | |||
≤40 | 10 | 16.4% | 16 | 36.4% | 0.023 c |
41-55 | 18 | 29.5% | 16 | 36.4% | 0.528c |
56-65 | 12 | 19.7% | 5 | 11.4% | 0.294c |
>65 | 21 | 34.4% | 7 | 15.9% | 0.044 c |
FIGO stage | |||||
I A/B | 40 | 65.6% | 19 | 43.2% | 0.029 c |
I C | 13 | 21.3% | 19 | 43.2% | 0.019 c |
II A-C | 1 | 1.6% | 2 | 4.5% | 0.570c |
III A/B | 3 | 4.9% | 3 | 6.8% | 0.693c |
III C | 4 | 6.6% | 1 | 2.3% | 0.396c |
IV | 0 | 0.0% | 0 | 0.0% | |
Histologic subtype | |||||
serous | 27 | 44.3% | 32 | 72.7% | 0.005 c |
seromucinous | 2 | 3.3% | 5 | 11.4% | 0.127c |
mucinous | 30 | 49.2% | 6 | 13.6% | < 0.001 c |
endometrioid | 2 | 3.3% | 1 | 2.3% | 1.000c |
Implants | |||||
yes | 8 | 13.1% | 2 | 4.5% | 0.140b |
- invasive | 1 | 0 | |||
- non-invasive | 7 | 2 | |||
no | 53 | 86.9% | 42 | 95.5% | |
Ascites | |||||
none | 27 | 44.3% | 18 | 40.9% | 0.468b |
< 500 ml | 22 | 36.1% | 11 | 25.0% | |
> 500 ml | 8 | 13.1% | 2 | 4.5% | |
unknown | 4 | 6.6% | 13 | 29.5% | |
CA 125 | 44.6 | 48.5 | 0.804a | ||
range | 2-2770 | 6-360 | |||
elevated | 27 | 44.3% | 16 | 36.4% | 0.594b |
within normal limits | 24 | 39.3% | 11 | 25.0% | |
unknown | 10 | 16.4% | 17 | 38.6% | |
BMI, median | 23,4 | 24.1 | 0.904a | ||
range | 17,7-43,0 | 18.6-35.3 | 17,7-43,0 | ||
< 19 | 3 | 4.9% | 1 | 2.3% | 0.677b |
19-24 | 23 | 37.7% | 15 | 34.1% | |
24-30 | 19 | 31.1% | 11 | 25.0% | |
>30 | 8 | 13.1% | 2 | 4.5% | |
unknown | 8 | 13.1% | 15 | 34.1% | |
ASA, median | 2 | 2 | 0.010 a | ||
range | 1-3 | 1-3 | 1-3 | ||
1 | 7 | 11.5% | 13 | 29.5% | 0.020 b |
2 | 31 | 50.8% | 14 | 31.8% | |
3 | 9 | 14.8% | 3 | 6.8% | |
unknown | 14 | 23.0% | 14 | 31.8% |